Interview with Loren D Walensky.
Loren D Walensky is an Associate Professor of Pediatrics at Harvard Medical School, faculty member in the Department of Pediatric Hematology/Oncology at Dana-Farber Cancer Institute/Children's Hospital Boston, and Medical Director of Dana-Farber's Program in Cancer Chemical Biology. He graduated as valedictorian from Princeton University in 1990, majoring in Chemistry and receiving a Certificate in Science Policy from the Woodrow Wilson School of Public and International Affairs. He went on to receive his MD and PhD from the Johns Hopkins University School of Medicine in 1997. Dr Walensky spoke to Isaac Bruce, Commissioning Editor of Future Medicinal Chemistry, about his career in therapeutic peptides, his involvement in collaborations and funding, and the future of peptides as therapy.
Loren D
LD
Walensky
D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D010455:Peptides / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D017433:Protein Structure, Secondary; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000737:chemistry; D054852:Small Molecule Libraries / Q000737:chemistry / Q000493:pharmacokinetics
D010455:Peptides; D019253:Proto-Oncogene Proteins c-bcl-2; D054852:Small Molecule Libraries